{"ticker": {"uuid": "bc6dae65-bc1b-4ce9-bff5-008a883df6a4", "symbol": "688321", "name": "Shenzhen Chipscreen Biosciences Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "ETFs Investing in Shenzhen Chipscreen Biosciences Co. Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5BaXFtM3ZHX09nSEpNSzU3ZzRQZFdxMnRhT0oyNkZ4cFZzdnVVNWl4YjFUVHllSG5QRkUzWEhjcFBEaklxLTVyWXQ3aFhpRC1YQ21mbUhNMVAxdGQ3WkJ0MzFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T12:34:02+00:00", "published_display": "17 Jul 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Shenzhen Chipscreen Biosciences Co. Ltd. Class A \u2013 SSE:688321", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNY0tZTC1IR1RfTmtLd2hNMWpIRmxJT0g2aG1qcEYzQzRPTTg2VWkyWlRqUGtkcllGYVl0WVQyZG9KWGxiVk9tcmFOcFRFdDhQUklCVE1fYkVRd0lQcF9UMzRzbGEtQ0poN0J1LUZFcDdwT0J1bHRuVWJVWGRKdkRCdFB0YWExaWpUc0dqZ3l3NXN3dVZkZ1c4TGVOT0stN1Rk?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T10:51:56+00:00", "published_display": "12 Jul 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chipscreen\u2019s PPAR pan-agonist Bilessglu wins NMPA nod for treatment of type 2 diabetes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPZnBCcllGS2ExeHZkZ3c5ejhqX0pHSjU5N29nWUpGbGY4czZIdWdwb1I3VFExV0hTUnJCRF9tUWttTHhwamlYZ0lSMXlyb3dDVTRVTGliTGNCdnI3NVN3MzBLRzJMZHZoeUltb0RnYS1tYmt5cGUydnFHTFhoU1FoOFV1ZlVaMUJWcUo1LVo1SkV5RHhfN2ZaMkd1amVFNTdOR01hd2pjN3FxTW8ycVZwNHRiSG9lSWZBQy1nQ3BJSkRmQVU3?oc=5", "source_name": "BioWorld News", "published_at": "2021-10-26T07:00:00+00:00", "published_display": "26 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chipscreen Poised to be One of the First IPOs on Shanghai\u2019s STAR Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNM0tqc21IandrRDJjaFlCaENfUG1Gb3hVMUdtRVJFUXprclFCUjNQVTFfR0FtV0RkZlJubUVsT3psVUZCdU5zSXp6OHFzRDdRYmNQcmF0ZGlmS2JwdG5kTTFhVTdvQWVUYmRLanRvckd2cTdpYkhMZ3NLdVNKNjNJTGM1cE5vb1dDeUxCUk5yNFZfWFZJUGNhXzluckswaDEyTjhTVHMyU0E?oc=5", "source_name": "NAI500", "published_at": "2019-07-19T07:00:00+00:00", "published_display": "19 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Shenzhen Chipscreen Biosciences Co. Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5BaXFtM3ZHX09nSEpNSzU3ZzRQZFdxMnRhT0oyNkZ4cFZzdnVVNWl4YjFUVHllSG5QRkUzWEhjcFBEaklxLTVyWXQ3aFhpRC1YQ21mbUhNMVAxdGQ3WkJ0MzFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-17T12:34:02+00:00", "published_display": "17 Jul 2026 12:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Shenzhen Chipscreen Biosciences Co. Ltd. Class A \u2013 SSE:688321", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNY0tZTC1IR1RfTmtLd2hNMWpIRmxJT0g2aG1qcEYzQzRPTTg2VWkyWlRqUGtkcllGYVl0WVQyZG9KWGxiVk9tcmFOcFRFdDhQUklCVE1fYkVRd0lQcF9UMzRzbGEtQ0poN0J1LUZFcDdwT0J1bHRuVWJVWGRKdkRCdFB0YWExaWpUc0dqZ3l3NXN3dVZkZ1c4TGVOT0stN1Rk?oc=5", "source_name": "TradingView", "published_at": "2026-07-12T10:51:56+00:00", "published_display": "12 Jul 2026 10:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chipscreen\u2019s PPAR pan-agonist Bilessglu wins NMPA nod for treatment of type 2 diabetes", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPZnBCcllGS2ExeHZkZ3c5ejhqX0pHSjU5N29nWUpGbGY4czZIdWdwb1I3VFExV0hTUnJCRF9tUWttTHhwamlYZ0lSMXlyb3dDVTRVTGliTGNCdnI3NVN3MzBLRzJMZHZoeUltb0RnYS1tYmt5cGUydnFHTFhoU1FoOFV1ZlVaMUJWcUo1LVo1SkV5RHhfN2ZaMkd1amVFNTdOR01hd2pjN3FxTW8ycVZwNHRiSG9lSWZBQy1nQ3BJSkRmQVU3?oc=5", "source_name": "BioWorld News", "published_at": "2021-10-26T07:00:00+00:00", "published_display": "26 Oct 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Chipscreen Poised to be One of the First IPOs on Shanghai\u2019s STAR Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNM0tqc21IandrRDJjaFlCaENfUG1Gb3hVMUdtRVJFUXprclFCUjNQVTFfR0FtV0RkZlJubUVsT3psVUZCdU5zSXp6OHFzRDdRYmNQcmF0ZGlmS2JwdG5kTTFhVTdvQWVUYmRLanRvckd2cTdpYkhMZ3NLdVNKNjNJTGM1cE5vb1dDeUxCUk5yNFZfWFZJUGNhXzluckswaDEyTjhTVHMyU0E?oc=5", "source_name": "NAI500", "published_at": "2019-07-19T07:00:00+00:00", "published_display": "19 Jul 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 48, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 71, "events": [{"event": "general", "label": "Market update", "weight": 1.65, "count": 3}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 27.95, "latest_week": "2026-07-17", "one_week_move": 0.8, "four_week_move": 9.9, "twelve_week_move": -6.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.43138, "market_dynamics_buy_signal": false, "relative_strength": -5.475227, "fair_value_gap": 17.8, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.7222, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.8% over one week, +9.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 45, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "BioWorld News", "count": 1}, {"label": "NAI500", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 3}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "71/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.8% over one week, +9.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Shenzhen Chipscreen Biosciences Co. Ltd. Class A Stocks"}], "updated_at": "2026-07-21T21:46:19.171449+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}